Emend - supply shortage
Resolved
aprepitant
ShortageHuman
Shortage information
The shortage affecting Emend has been resolved and the information and recommendations which were issued during the shortage no longer apply.
Key facts
- Medicines affected
- Emend
- Supply shortage status
- Resolved
- International non-proprietary name (INN) or common name
- aprepitant
- Therapeutic area (MESH)
- Vomiting
- Postoperative Nausea and Vomiting
- Cancer
- Neoplasms
- Pharmaceutical forms affected
- Powder for oral suspension
- Strengths affected
- 80 mg
- 125 mg
Key dates
- First published
- Last updated